Silverfin false false 31/10/2024 01/11/2023 31/10/2024 D Richards 24/10/2006 02 December 2024 The principal activity of the Company during the financial year was that of the provision of pharmaceutical services. 05975924 2024-10-31 05975924 bus:Director1 2024-10-31 05975924 core:CurrentFinancialInstruments 2024-10-31 05975924 core:CurrentFinancialInstruments 2023-10-31 05975924 2023-10-31 05975924 core:ShareCapital 2024-10-31 05975924 core:ShareCapital 2023-10-31 05975924 core:RetainedEarningsAccumulatedLosses 2024-10-31 05975924 core:RetainedEarningsAccumulatedLosses 2023-10-31 05975924 bus:OrdinaryShareClass1 2024-10-31 05975924 2023-11-01 2024-10-31 05975924 bus:FilletedAccounts 2023-11-01 2024-10-31 05975924 bus:SmallEntities 2023-11-01 2024-10-31 05975924 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 05975924 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 05975924 bus:Director1 2023-11-01 2024-10-31 05975924 2022-11-01 2023-10-31 05975924 bus:OrdinaryShareClass1 2023-11-01 2024-10-31 05975924 bus:OrdinaryShareClass1 2022-11-01 2023-10-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 05975924 (England and Wales)

NIAMOR LTD

Unaudited Financial Statements
For the financial year ended 31 October 2024
Pages for filing with the registrar

NIAMOR LTD

Unaudited Financial Statements

For the financial year ended 31 October 2024

Contents

NIAMOR LTD

STATEMENT OF FINANCIAL POSITION

As at 31 October 2024
NIAMOR LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 October 2024
Note 2024 2023
£ £
Current assets
Debtors 3 1,836 2,016
Cash at bank and in hand 15,732 20,344
17,568 22,360
Creditors: amounts falling due within one year 4 ( 1,894) ( 1,321)
Net current assets 15,674 21,039
Total assets less current liabilities 15,674 21,039
Net assets 15,674 21,039
Capital and reserves
Called-up share capital 5 100 100
Profit and loss account 15,574 20,939
Total shareholder's funds 15,674 21,039

For the financial year ending 31 October 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Niamor Ltd (registered number: 05975924) were approved and authorised for issue by the Director on 02 December 2024. They were signed on its behalf by:

D Richards
Director
NIAMOR LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 October 2024
NIAMOR LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 October 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Niamor Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Romain Tucking Mill Lane, Midford, Bath, BA2 7DA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Statement of Income and Retained Earnings in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Statement of Financial Position.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including the director 1 1

3. Debtors

2024 2023
£ £
Trade debtors 1,836 2,016

4. Creditors: amounts falling due within one year

2024 2023
£ £
Accruals 1,894 1,321

5. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each 100 100